Terms: = Lung cancer AND PHOX2B, 8929
8 results:
1. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell lung cancer: An Open-Label, Single-Arm, Phase 2 Study.
Peled N; Roisman LC; Levison E; Dudnik J; Chernomordikov E; Heching N; Dudnik E; Keren-Rosenberg S; Nechushtan H; Salhab A; Hershkovitz D; Tsuriel S; Hannes V; Rotem O; Lazarev I; Lichtenberg R; Granot IS; Krayim B; Shalata W; Levin D; Krutman Y; Allen AM; Blumenfeld P; Lavrenkov K; Kian W
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):105-114. PubMed ID: 36925073
[TBL] [Abstract] [Full Text] [Related]
3. cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
Cook MB; Coburn SB; Lam JR; Taylor PR; Schneider JL; Corley DA
Gut; 2018 Mar; 67(3):418-529. PubMed ID: 28053055
[TBL] [Abstract] [Full Text] [Related]
4. phox2b is a suppressor of neuroblastoma metastasis.
Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
[TBL] [Abstract] [Full Text] [Related]
5. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
[TBL] [Abstract] [Full Text] [Related]
6. A study of gata3 and phox2b expression in tumors of the autonomic nervous system.
Nonaka D; Wang BY; Edmondson D; Beckett E; Sun CC
Am J Surg Pathol; 2013 Aug; 37(8):1236-41. PubMed ID: 23715162
[TBL] [Abstract] [Full Text] [Related]
7. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
[TBL] [Abstract] [Full Text] [Related]
8. lung-residing metastatic and dormant neuroblastoma cells.
Edry Botzer L; Maman S; Sagi-Assif O; Meshel T; Nevo I; Bäuerle T; Yron I; Witz IP
Am J Pathol; 2011 Jul; 179(1):524-36. PubMed ID: 21703429
[TBL] [Abstract] [Full Text] [Related]